or Try an Advanced Search...

    Technical Analysis for ALPN - Alpine Immune Sciences, Inc.

    Grade Last Price % Change Price Change
    A 64.57 0.03% 0.02
    ALPN closed up 0.03 percent on Wednesday, April 24, 2024, on 49 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    Earnings due: May 9
    *** please verify all earnings dates ***
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Flat
    Historical ALPN trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 37.27%
    MACD Bullish Signal Line Cross Bullish 37.27%
    New 52 Week Closing High Bullish 37.27%
    Expansion Breakout Bullish Swing Setup 37.27%
    Pocket Pivot Bullish Swing Setup 37.27%
    Reversal New Highs Setup Bullish Swing Setup 37.27%
    Volume Surge Other 37.27%
    Wide Range Bar Range Expansion 37.27%
    New 52 Week High Strength 37.27%
    20 DMA Support Bullish 65.82%
    Older End-of-Day Signals for ALPN ...

       Recent Intraday Alerts

    Alert Time
    Gapped Down (Partial) 14 days ago
    20 DMA Support 14 days ago
    10 DMA Support 14 days ago
    Reversal New Highs Entry 14 days ago
    Rose Above Previous Day's High 14 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ALPN Chart by TradingView
    Basic chart:

    Profile

    Alpine Immune Sciences, Inc., a development-stage specialty pharmaceutical company, engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. It is developing ALPN-101, an ICOS/CD28 antagonist program for the treatment of inflammatory diseases. The company is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases

    Is ALPN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 18 Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
    Apr 15 Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?
    Apr 15 Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
    Apr 13 Could This Stock Be the Next Biotech Buyout?
    Apr 12 Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
    Apr 12 Health Care Roundup: Market Talk
    Apr 11 Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement
    Apr 11 Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
    Apr 11 What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences
    Apr 11 Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
    See more ALPN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 64.7
    52 Week Low 6.71
    Average Volume 2,415,047
    200-Day Moving Average 21.78
    50-Day Moving Average 41.94
    20-Day Moving Average 51.77
    10-Day Moving Average 64.48
    Average True Range 2.21
    RSI (14) 83.42
    ADX 52.41
    +DI 54.30
    -DI 9.43
    Chandelier Exit (Long, 3 ATRs) 58.06
    Chandelier Exit (Short, 3 ATRs) 40.89
    Upper Bollinger Bands 77.58
    Lower Bollinger Band 25.96
    Percent B (%b) 0.75
    BandWidth 99.70
    MACD Line 7.72
    MACD Signal Line 6.77
    MACD Histogram 0.9549
    Fundamentals Value
    Market Cap 4.23 Billion
    Num Shares 65.5 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -50.05
    Price-to-Sales 64.64
    Price-to-Book 11.77
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 64.68
    Resistance 3 (R3) 64.68 64.66 64.66
    Resistance 2 (R2) 64.66 64.63 64.65 64.65
    Resistance 1 (R1) 64.61 64.61 64.61 64.61 64.65
    Pivot Point 64.59 64.59 64.58 64.58 64.59
    Support 1 (S1) 64.54 64.56 64.54 64.54 64.49
    Support 2 (S2) 64.52 64.54 64.51 64.49
    Support 3 (S3) 64.47 64.52 64.48
    Support 4 (S4) 64.47